Omnimed Capital LLC
Dallas, TX · CRD 326628
Private equity managerExempt reporting
Omnimed Capital LLC is an exempt reporting adviser based in Dallas, TX that reports managing 4 private funds on Form ADV, including 4 private equity funds. Its private funds hold $56.1 million in gross assets.
- Regulatory assets under management
- —Form ADV Item 5.F
- Gross assets of private funds
- $56.1 millionAll private fund types, Form ADV
- Private funds managed
- 4PE 4 · VC 0 · hedge 0
- Employees
- —Form ADV Item 5.A
- Registration
- Exempt reporting adviserCRD 326628
- Latest Form ADV
- 03/31/2026Disciplinary disclosures: none reported
Private equity funds filing Form D (2)
Fund
First sale
Raised
Investors
Minimum
Offering
Omnimed Equity Partners II LP
Dallas, TXEmerging
First saleAug 2022
Raised$10.6M
Investors60
Minimum$100K
Offering506(b)
Omnimed A.I. Partners, L.P.
Dallas, TXEmerging
First saleJun 2026
Raised$3.5M
Investors21
Minimum$100K
Offering506(b)
Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.
Private funds reported on Form ADV (2)
Fund
Gross assets
Minimum
Owners
Adviser
Omnimed Equity Partners, LP
Texas, United StatesPrivate equity fund
Gross assets$23.5M
Minimum$100K
Owners78
AdviserOmnimed Capital LLC
Omnimed Equity Partners II LP
Texas, United StatesPrivate equity fund
Gross assets$9.3M
Minimum$100K
Owners63
AdviserOmnimed Capital LLC
As reported in the adviser's Form ADV filed Mar 28, 2024. Funds also listed from Form D are shown above.
Fund vehicles: feeder funds and single-deal vehicles (1)
Fund
Gross assets
Minimum
Owners
Adviser
Omnimed Equity Partners Coinvest, LP
Texas, United StatesPrivate equity fund
Gross assets$6.5M
Minimum$100K
Owners11
AdviserOmnimed Capital LLC
Feeder funds invest through a master fund; single-deal vehicles (SPVs, co-investments, series) hold one investment.
From SEC filings. Firm data comes from the SEC's Form ADV data. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures